GDNF and glycogen storage disease VI: For example, the orallyactive compound, PYM50028, which elevates striatal levels of GDNF, is protectiveagainst MPTP toxicity in mice [47], and induction of GDNF is associated with theneurorescue action of rasagilin, a drug of current use in the treatment ofParkinson's disease [48], [49].